Back to Search
Start Over
Current Threat of Triclabendazole Resistance in Fasciola hepatica.
- Source :
-
Trends in parasitology [Trends Parasitol] 2016 Jun; Vol. 32 (6), pp. 458-469. Date of Electronic Publication: 2016 Apr 02. - Publication Year :
- 2016
-
Abstract
- Triclabendazole (TCBZ) is the only chemical that kills early immature and adult Fasciola hepatica (liver fluke) but widespread resistance to the drug greatly compromises fluke control in livestock and humans. The mode of action of TCBZ and mechanism(s) underlying parasite resistance to the drug are not known. Due to the high prevalence of TCBZ resistance (TCBZ-R), effective management of drug resistance is now critical for sustainable livestock production. Here, we discuss the current status of TCBZ-R in F. hepatica, the global distribution of resistance observed in livestock, the possible mechanism(s) of drug action, the proposed mechanisms and genetic basis of resistance, and the prospects for future control of liver fluke infections using an integrated parasite management (IPM) approach.<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animal Husbandry trends
Animals
Anthelmintics pharmacology
Anthelmintics therapeutic use
Benzimidazoles therapeutic use
Fascioliasis drug therapy
Fascioliasis parasitology
Fascioliasis prevention & control
Livestock
Triclabendazole
Benzimidazoles pharmacology
Drug Resistance genetics
Fasciola hepatica drug effects
Fascioliasis veterinary
Subjects
Details
- Language :
- English
- ISSN :
- 1471-5007
- Volume :
- 32
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Trends in parasitology
- Publication Type :
- Academic Journal
- Accession number :
- 27049013
- Full Text :
- https://doi.org/10.1016/j.pt.2016.03.002